Dudediligence.

BioAge Labs, Inc

BIOANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$1.5MMar ’25$2.4MJun ’25$2.1MSep ’25$3.1MDec ’25$2.8MMar ’26$2.5MJun ’26
Net income, by quarter
−$23.4MSep ’24−$21.1MDec ’24−$12.9MMar ’25−$21.6MJun ’25−$20.2MSep ’25−$25.9MDec ’25−$22.3MMar ’26−$26.1MJun ’26
Fiscal years, by the month each ended
LineDec 2023Dec 2024Dec 2025
Revenuenone on file$0.00$9.0M
Operating income−$48.4M−$78.2M−$92.8M
Net income−$63.9M−$71.1M−$80.6M
Operating cash flow−$37.4M−$51.5M−$81.6M
Free cash flow−$37.5M−$51.9M−$82.3M
Cash$21.6M$354.3M$188.9M
Debt$14.2M$8.5M$2.6M
Shares outstanding1.7M35.9M37.4M